Urology coding is evolving — and so is the support available to practices navigating it. Veradigm is heading to the Specialty Alliance Annual Meeting in Chicago June 12–13.
Hope to see you there!
#SpecialtyAlliance#MedicalCoding#RCS#HealthIT
Veradigm is here at Florida OrthoCon 2026 and we can’t wait to see you!
Veradigm helps orthopedic and MSK practices reduce denials, increase revenue, and simplify billing—all without switching your EHR.
#FOS#FAOE
We’re gearing up for Becker’s!
Our team is looking forward to powerful conversations and the opportunity to support independent orthopedic practices with revenue cycle and coding services that outperform industry standards.
We hope to see you there!
#BeckersASC
May is ending. The work isn't. 148M+ patients. 3 life stages. Data that demands action. Download our 2026 Women's Health RWE Report. https://t.co/SYVUGT5ERK
#WomensHealthMonth#RWE
Veradigm is proud to be part of Scaling Omnichannel: Building the Business Case for Sustainable Growth. Industry experts will share how leading organizations are moving beyond campaigns to scalable, value‑driven omnichannel ecosystems.
#futurepharma#pharmamarketing
Download our report: https://t.co/I1XzAoGzAK
Women are living longer than ever. But our 2026 RWE data — drawn from 148M+ patients — shows they're also carrying more. More chronic conditions. More untreated symptoms. More gaps in care. The data exists to change this. #RWE
We’re gearing up for The Millennium Alliance Healthcare Payers Transformation Assembly, June 2–3!
Will we see you there?
#HealthcarePayers#MillenniumLive
Future Pharma is almost here, and we can’t wait to connect with industry leaders in Boston!
Stop by our booth to learn how Veradigm helps pharma organizations strengthen commercial strategy and leverage actionable data to better support patients and providers.
#futurepharma
We’re excited to be part of 2026 FL OrthoCon this June in Orlando!
We look forward to connecting and sharing how Veradigm supports smarter, data‑driven workflows for orthopedic practices.
See you in Orlando!
#FOS#FAOE
Clinical and claims data show what happened. Patient-reported outcomes reveal why.
Learn why PROs are now essential to real world evidence for life sciences.
Read the blog: https://t.co/b9Go5hQxdu
#RealWorldEvidence#lifesciences
Most real-world evidence programs are missing a critical layer.
Veradigm's RWE PRO Surveys link patient voice directly to the clinical records that give it context.
Learn more: https://t.co/JKFpxf3aC0
#RealWorldEvidence#HEOR#lifesciences#marketaccess#veradigm
We’re excited to head to Boston for Future Pharma 2026!
This event brings together commercial, marketing, digital, and patient‑engagement leaders to discuss the evolving landscape of pharma innovation.
See you in Boston!
#futurepharma#PharmaMarketing
Independent physician practices remain committed to independence, but sustaining it is getting harder.
Explore the key findings and download the white paper for a closer look at the data behind these trends: https://t.co/S31ZF7CkKa
#PracticeManagement#revenuecycle
Veradigm's RWE PRO Surveys bring the patient voice to the center of real-world evidence — at scale, in real time, integrated with the clinical data you already have.
🔗 Learn more: https://t.co/LbkRpf1shX
#RealWorldEvidence#PatientReportedOutcomes#HEOR#LifeSciences
State of Franklin Healthcare Associates (SOFHA) saw higher claim accuracy and smoother revenue cycle performance after collaborating with Veradigm Revenue Cycle Services.
Discover the impact: https://t.co/fcfUv5mzDp
#RevenueCycleManagement#MedicalBilling#ClaimAccuracy
We’re at ISPOR 2026—and ready to talk real‑world evidence at the point of care.
Stop by the Veradigm booth to explore next‑generation, data‑driven insights—from the point of care to everyday life.
#ISPORAnnual#RWE#HEOR
Women are living longer than ever. But our 2026 RWE data — drawn from 148M+ patients — shows they're also carrying more. More chronic conditions. More untreated symptoms. More gaps in care. The data exists to change this. https://t.co/cPS1EkrVFb
#WomensHealthWeek#RWE
Fewer than 1 in 10 eligible women received hormone replacement therapy in 2024. Not because they weren't candidates. Because clinical hesitancy and access barriers got in the way. The evidence supports HRT. The practice hasn't caught up. https://t.co/AuPK8JakK8